📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Pharmacopeia

1.1 - Company Overview

Pharmacopeia Logo

Pharmacopeia

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of biopharmaceutical discovery and development focused on therapeutics addressing significant medical needs, including an internal program portfolio led by PS433540, a dual-acting angiotensin and endothelin receptor antagonist in phase II clinical development for cardiovascular and renal indications.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Pharmacopeia

SciFluor Logo

SciFluor

HQ: United States Website
  • Description: Provider of fluorination technologies that improve drug properties, such as metabolic stability and potency.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full SciFluor company profile →
DiaMedica Therapeutics Logo

DiaMedica Therapeutics

HQ: United States Website
  • Description: Provider of biopharmaceutical R&D focused on treatments for stroke, developing DM199, a recombinant human tissue kallikrein-1 (KLK1) intended to treat acute ischemic stroke and cardio-renal diseases by restoring KLK1 levels, and conducting the ReMEDy2 adaptive, randomized, double-blind, placebo-controlled trial to study DM199’s efficacy and safety in acute ischemic stroke.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full DiaMedica Therapeutics company profile →
LEAF Pharmaceuticals Logo

LEAF Pharmaceuticals

HQ: United States Website
  • Description: Provider of biotechnology and healthcare products, including investigational anticancer drugs targeting solid tumors (LEAF-1401, LEAF-1701) with preclinical results showing reduced metastatic tumor burden in lung cancer models, superior performance in colorectal models, and minimal myelosuppression and gastrointestinal toxicity, plus LEAF-1404, a complex generic anticancer medicine manufactured under global cGMP.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full LEAF Pharmaceuticals company profile →
Psycheceutical Logo

Psycheceutical

HQ: United States Website
  • Description: Provider of patented delivery technologies for safe, bioavailable psychedelic pharmaceutical medicines, featuring NeuroDirect non-systemic topical delivery of neuro-active compounds directly into nerve tissue for immediate, sustained effects with dosage control and minimized systemic side effects, and a NeuroDirect ketamine topical in Phase I for PTSD targeting nerve endings without hallucinogenic effects.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Psycheceutical company profile →
Talecris Logo

Talecris

HQ: Spain Website
  • Description: Provider of plasma-derived protein therapies, produced and marketed by a biopharmaceutical company founded in 2004 and based in Barcelona, Spain.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Talecris company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Pharmacopeia

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Pharmacopeia

2.2 - Growth funds investing in similar companies to Pharmacopeia

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Pharmacopeia

4.2 - Public trading comparable groups for Pharmacopeia

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Pharmacopeia

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Pharmacopeia

What does Pharmacopeia do?

Pharmacopeia is a provider of biopharmaceutical discovery and development focused on therapeutics addressing significant medical needs, including an internal program portfolio led by PS433540, a dual-acting angiotensin and endothelin receptor antagonist in phase II clinical development for cardiovascular and renal indications.

Who are Pharmacopeia's competitors?

Pharmacopeia's competitors and similar companies include SciFluor, DiaMedica Therapeutics, LEAF Pharmaceuticals, Psycheceutical, and Talecris.

Where is Pharmacopeia headquartered?

Pharmacopeia is headquartered in United States.

How many employees does Pharmacopeia have?

Pharmacopeia has 1,000 employees 🔒.

When was Pharmacopeia founded?

Pharmacopeia was founded in 2010 🔒.

What sector and industry vertical is Pharmacopeia in?

Pharmacopeia is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Pharmacopeia

Who are the top strategic acquirers in Pharmacopeia's sector and industry

Top strategic M&A buyers and acquirers in Pharmacopeia's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Pharmacopeia?

Top strategic M&A buyers groups and sectors for Pharmacopeia include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Pharmacopeia's sector and industry vertical

Which are the top PE firms investing in Pharmacopeia's sector and industry vertical?

Top PE firms investing in Pharmacopeia's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Pharmacopeia's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Pharmacopeia's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Pharmacopeia's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Pharmacopeia include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Pharmacopeia's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Pharmacopeia?

The key public trading comparables and valuation benchmarks for Pharmacopeia include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Pharmacopeia for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Pharmacopeia with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Pharmacopeia's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Pharmacopeia with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Pharmacopeia's' sector and industry vertical?

Access recent funding rounds and capital raises in Pharmacopeia's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Pharmacopeia